(Jul 04) [Independence Day] A 27-year-old who worked for Apple as a teenager wants to make a yearly blood test to diagnose cancer and he just got .5 million from Silicon Valley VCs to pull it off Researchers looked at cells sampled from 308 people with pancreatic cancer, finding mutations in gene promoter regions that provide important clues about pathways perturbed in the illness and suggesting new targets for future treatments.
Over the last decade, it has made good sense to study the genetic drivers of cancer by sequencing a tiny portion of the human genome called the exome -- the 2% of our three billion base pairs that "spell out" the 21,000 genes in our chromosomes.
strives to understand normal body functioning and disease pathogenesis at the molecular level, which may allow researchers and physician-scientists to use that knowledge in the design of specific molecular tools for disease diagnosis, treatment, prognosis, and prevention.
Manuscripts submitted to the journal should maintain this focus and describe the implications for human disease, at a level approachable by the broad readership of publishes work in the format of original research articles, review articles, editorials, commentaries, and letters to the editor covering emerging concepts in the interdisciplinary field of molecular medicine.
Amidst the pan-galactic warfare, many planets—including Mandalore and other members of the Council of Neutral Systems—struggled to remain neutral, but found it difficult to escape from the carnage.In dating sites, science-based online dating sites are those pair-matching websites that claim to use “science”, such as chemistry, genetics, psychology, or the scientific method, etc., to match up potential couples. , motto: “lets people experience real chemistry”, a subsidiary of (Alexa-rank: 310), launched in 2006 and developed, in large part, on the theories of American anthropologist Helen Fisher, which claims to match people according to compatibility and chemistry."Promoters are important in determining when specific genes are turned on and off," says Feigin, "and I became interested in figuring out whether mutations within promoters -- as opposed to within the genes they regulate -consistently affects the way cancers develop and sustain themselves." The team "looked all across the genome," Feigin says, "and, interestingly, while we did find mutations in promoters, we never found clusters of these mutations near any of the genes that prior research had already told us were typically mutated in pancreatic cancer." Genes called KRAS and p53 are mutated in the majority of pancreas cancer cells, for example.But mutations in promoters sifted out of mountains of data by the team's novel mathematical formula, or algorithm, called GECCO, lay in genes never before implicated in pancreatic cancer.